Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?

PURPOSE: We aimed to compare the overall (OS) and disease-free survival (DFS) of patients undergoing orthotopic liver transplant (OLT) for hepatocellular carcinoma who did and did not have neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE). METHODS: This is a retros...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diagn Interv Radiol
Главные авторы: Dorcaratto, Dimitri, Udupa, Venkatesha, Hogan, Niamh M., Brophy, David P., McCann, Jeffrey W., Maguire, Donal, Geoghegan, Justin, Cantwell, Colin P., Hoti, Emir
Формат: Artigo
Язык:Inglês
Опубликовано: Turkish Society of Radiology 2017
Предметы:
Interventional Radiology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669544/
https://ncbi.nlm.nih.gov/pubmed/29063856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/dir.2017.17106
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы